Antonio A. W. L. Wong

Mr. Antonio A. W. L. Wong

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Arsyangela VerenaArsyangela Verena
Arsyangela Verena
ZZZhengxing Zhang
Zhengxing Zhang
HKHsiou-Ting Kuo
Hsiou-Ting Kuo
HMHelen Merkens
Helen Merkens
JZJutta Zeisler
Jutta Zeisler
KLKuo-Shyan Lin
Kuo-Shyan Lin
Tumor heterogeneity limits the efficacy and reliability of monospecific radiopharmaceuticals in prostate cancer diagnosis and therapy. To overcome this limitation and improve lesion detection sensitivity, we developed and evaluated three bispecific radiotracers that can target both prostate-specific membrane antigen (PSMA) and fibroblast activation protein (FAP), which are the two key proteins overexpressed in prostate cancer. Three FAP-targeting ligands with various linker lengths were synthesized through multistep organic synthesis, and then connected to the PSMA-targeting motif. IC50(PSMA) and IC50(FAP) values of Ga-complexed bispecific ligands, Ga-AV01017, Ga-AV01030, and Ga-AV01038 were 25.2–71.6 and 1.25–2.74 nM, respectively. The uptake values in PSMA-expressing LNCaP tumor xenografts were 4.38 ± 0.55, 5.17 ± 0.51, and 4.25 ± 0.86 %ID/g for [68Ga]Ga-AV01017, [68Ga]Ga-AV01030, and [68Ga]Ga-AV01038, respectively, which were lower than the monospecific PSMA-targeting tracer [68Ga]Ga-HTK03041 (23.1 ± 6.11 %ID/g). The uptake values in FAP-expressing HEK293T:hFAP tumor xenografts were 2.99 ± 0.37, 3.69 ± 0.81, 3.64 ± 0.83 %ID/g for [68Ga]Ga-AV01017, [68Ga]Ga-AV01030, and [68Ga]Ga-AV01038, respectively, which were also lower than the monospecific FAP-targeting tracer, [68Ga]Ga-FAPI-04 (12.5 ± 2.00 %ID/g). We observed that the bispecific tracers had prolonged blood retention, in which tracers with a longer linker tend to have a higher blood uptake and lower tumor uptake. Further investigations are needed to optimize the linker selection to generate promising bispecific PSMA/FAP-targeting tracers for prostate cancer imaging.

13 June 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MTMihajlo Todorovic
Mihajlo Todorovic
PRPaul Rivollier
Paul Rivollier
AWAntonio A. W. L. Wong
Antonio A. W. L. Wong
ZWZhou Wang
Zhou Wang
APAlla Pryyma
Alla Pryyma
DPDavid Perrin
David Perrin

31 May 2021 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
KMKaveh Matinkhoo
Kaveh Matinkhoo
AWAntonio A. W. L. Wong
Antonio A. W. L. Wong
CHChido M. Hambira
Chido M. Hambira
BKBrandon Kato
Brandon Kato
CWCharlie Wei
Charlie Wei
DPDavid Perrin
David Perrin

8 December 2021 in ChemBioChem
Verified
Journal Article
Open access
PDF file
SPSomdeb Paul
Somdeb Paul
AWAntonio A. W. L. Wong
Antonio A. W. L. Wong
LLLeo T. Liu
Leo T. Liu
DPDavid Perrin
David Perrin
Sequence‐specific cleavage of RNA by nucleic acid catalysts in the absence of a divalent metal cation (M2+) has remained an important goal in biomimicry with potential therapeutic applications. Given the lack of functional group diversity in canonical nucleotides, modified nucleotides with amino acid‐like side chains were used to enhance self‐cleavage rates at a single embedded ribonucleoside site. Previous works relied on three functional groups: an amine, a guanidine and an imidazole ensconced on three different nucleosides. However, to date, few studies have systematically addressed the necessity of all three modifications, as the value of any single modified nucleoside is contextualized at the outset of selection. Herein, we report on the use of only two modified dNTPs, excluding an imidazole, i. e. 5‐(3‐guanidinoallyl)‐2’‐dUTP (dUgaTP) and 5‐aminoallyl‐2′‐dCTP (dCaaTP), to select in‐vitro self‐cleaving DNAzymes that cleave in the absence of M2+ in a pH‐independent fashion. Cleavage shows biphasic kinetics with rate constants that are significantly higher than in unmodified DNAzymes and compare favorably to certain DNAzymes involving an imidazole.

15 October 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
APAlla Pryyma
Alla Pryyma
KMKaveh Matinkhoo
Kaveh Matinkhoo
AWAntonio A. W. L. Wong
Antonio A. W. L. Wong
DPDavid Perrin
David Perrin
Appreciating the need to access synthetic analogs of amanitin, here we report the synthesis of 5′-hydroxy-6′-deoxy-amanitin, a novel, rationally-designed bioactive analog and constitutional isomer of α-amanitin, that is anticipated to be used as a payload for antibody drug conjugates. In completing this synthesis, we meet the challenge of diastereoselective sulfoxidation by presenting two high-yielding and diastereoselective sulfoxidation approaches to afford the more toxic (R)-sulfoxide.

16 March 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Arsyangela VerenaArsyangela Verena
Arsyangela Verena
HKHsiou-Ting Kuo
Hsiou-Ting Kuo
HMHelen Merkens
Helen Merkens
JZJutta Zeisler
Jutta Zeisler
SBShreya Bendre
Shreya Bendre
KLKuo-Shyan Lin
Kuo-Shyan Lin
Compared to quinoline-based fibroblast activation protein (FAP)-targeted radiotracers, pyridine-based FAP-targeted tracers are expected to have faster pharmacokinetics due to their smaller molecular size and higher hydrophilicity, which we hypothesize would improve the tumor-to-background image contrast. We aim to develop 68Ga-labeled pyridine-based FAP-targeted tracers for cancer imaging with positron emission tomography (PET), and compare their imaging potential with the clinically validated [68Ga]Ga-FAPI-04. Two DOTA-conjugated pyridine-based AV02053 and AV02070 were synthesized through multi-step organic synthesis. IC50(FAP) values of Ga-AV02053 and Ga-AV02070 were determined by an enzymatic assay to be 187 ± 52.0 and 17.1 ± 4.60 nM, respectively. PET imaging and biodistribution studies were conducted in HEK293T:hFAP tumor-bearing mice at 1 h post-injection. The HEK293T:hFAP tumor xenografts were clearly visualized with good contrast on PET images by [68Ga]Ga-AV02053 and [68Ga]Ga-AV02070, and both tracers were excreted mainly through the renal pathway. The tumor uptake values of [68Ga]Ga-AV02070 (7.93 ± 1.88%ID/g) and [68Ga]Ga-AV02053 (5.6 ± 1.12%ID/g) were lower than that of previously reported [68Ga]Ga-FAPI-04 (12.5 ± 2.00%ID/g). However, both [68Ga]Ga-AV02070 and [68Ga]Ga-AV02053 showed higher tumor-to-background (blood, muscle, and bone) uptake ratios than [68Ga]Ga-FAPI-04. Our data suggests that pyridine-based pharmacophores are promising for the design of FAP-targeted tracers. Future optimization on the selection of a linker will be explored to increase tumor uptake while maintaining or even further improving the high tumor-to-background contrast.